Please ensure Javascript is enabled for purposes of website accessibility

Here's What This $17 Billion Money Manager Has Been Buying

By Selena Maranjian - Sep 13, 2013 at 11:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Does this surging biotech company interest you?

Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks.

Today, let's look at Fred Alger Management, founded in 1964, and managing mutual funds, pension funds, and more. The company explains, "We have remained steadfast to our philosophy and proprietary, bottom-up, fundamental research process, which we believe is the blueprint for our long-standing success." The company was devastated on Sept. 11, 2001, when the majority of its employees who worked at One World Trade Center were killed, but it remains in business, having regrouped.

The company's reportable stock portfolio totaled $16.8 billion in value as of June 30, 2013.

Interesting developments
So what does Fred Alger Management's latest quarterly 13F filing tell us? Here are a few interesting details:

The biggest new holdings are NXP Semiconductors and General Motors. Other new holdings of interest include Santarus (NASDAQ: SNTS). Biotech company Santarus has surged some 164% over the past year, with its ulcerative colitis drug Uceris having received FDA approval. Its second quarter featured revenue up 89%, and management upping projections. The company has five drugs on the market, with three of them posting double-digit growth. It has more in its pipeline, too.

Among holdings in which Fred Alger Management increased its stake were speech-recognition software specialist Nuance Communications (NUAN), and Chinese search-engine giant Baidu (BIDU 0.70%). Nuance is a major developer of speech-recognition software, with its technology housed in many Apple devices (think "Siri"). It has been seen as a buyout candidate (perhaps even by Apple), and with activist investor Carl Icahn having gobbled up many shares, the company recently swallowed a "poison pill," limiting takeover possibilities. While some see the stock as undervalued now, others are bailing on the company, not liking its recent performance or its CEO's compensation package. The company's future is quite uncertain, but bulls see potential, such as in the health-care industry's looming deadline to update its coding system.

Chinese search-engine giant Baidu (BIDU 0.70%), for example, advanced 19%. It has suffered as China's economic growth has slowed, and has also faced tough competition. Its second quarter featured strong earnings and a rosy outlook. Bulls like its profitability and growth prospects, such as in video, smart TVs, and mobile apps. Also promising is its "Light App" strategy that could profit from sales of less popular apps, capturing the "long tail" of the market. Baidu has been frustrating its short-sellers with its surging price.

Fred Alger Management reduced its stake in lots of companies, including Cliffs Natural Resources (CLF 1.13%). The company has suffered in a weak coal market, but some expect coal prices to rebound and demand to grow, especially abroad. (Cliffs' CEO has noted that iron ore inventory levels in China have been near multi-year lows, and the Chinese economy is showing signs of heating up.) With significant debt, and little to no free cash flow, the stock has been heavily shorted. Some on Wall Street see it as overvalued now, and have downgraded it and trimmed price targets.

Finally, Fred Alger Management's biggest closed positions included News Corp. and Open Table. Other closed positions of interest include rare-earth-materials specialist Molycorp (NYSE: MCP). It has been struggling due to oversupply in the market, and worried investors earlier this year with a surprisingly large share offering and debt issuance. Some also worry about it running out of money before its market turns around -- it has been burning much more cash annually than it has on hand right now. Molycorp's second quarter featured revenue up, but not as much as expected, and net losses much wider than expected. Bulls hope Molycorp can hang on, seeing demand eventually increasing. The company has competition, though, and a rise in production could hurt pricing.

We should never blindly copy any investor's moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. Therefore, 13-F forms can be great places to find intriguing candidates for our portfolios.

Longtime Fool contributor Selena Maranjianwhom you can follow on Twitter, owns shares of Apple and Baidu. The Motley Fool recommends Apple, Baidu, General Motors, Nuance Communications, NXP Semiconductors , and OpenTable. The Motley Fool owns shares of Apple, Baidu, and Nuance Communications. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Nuance Communications, Inc. Stock Quote
Nuance Communications, Inc.
Cliffs Natural Resources Inc. Stock Quote
Cliffs Natural Resources Inc.
$19.67 (1.13%) $0.22
Baidu, Inc. Stock Quote
Baidu, Inc.
$140.36 (0.70%) $0.98

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.